Tag: schedule III substances
Despite āFlurry of Interest,ā Ketamine Remains Unproven For Depression
In 2014, then National Institute of Mental Health (NIMH) director, Thomas Insel, speculated that ketamine āmight be the most important breakthrough in antidepressant treatment in decades.ā A recent review of the research suggests that while ketamine may produce a rapid short-term improvement in depression, the effect is short-lived and the potential for addiction and dependence warrants considerable caution.
